Author: Boutayna Chokrane

Locust Valley, New York–(Newsfile Corp. – February 12, 2026) – Two Hands Corporation (CSE: TWOH) (OTCID: TWOH) (“Two Hands” or the “Company”) is pleased to announce significant progress in its strategic transformation into an AI- and mobile app-focused technology platform, targeting high-growth markets in India and Southeast Asia. The Company has invested in ON GRAPH, a project to develop a n AI platform centered on character creation and companion experiences. This platform will integrate…Read More

Read More

BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune and inflammatory diseases, today announced that Lucinda Warren, who has served as Cue Biopharma’s chief business officer (CBO) since September 2024, has been appointed chief financial and business officer (CFBO) effective February 9, 2026Read More

Read More